Status:
UNKNOWN
The Impact of Vitamin D Supplementation on Pregnant Women With the Risk of GDM
Lead Sponsor:
IIMC, Riphah International University, Pakistan
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
21-40 years
Phase:
NA
Brief Summary
A clinical trial will be conducted in Chemical pathology department in collaboration with Gyne \&Obs department of PRH, IIMC over a period of 02 years w.e.f. December 15, 2023. 350 pregnant women with...
Detailed Description
Gestational diabetes mellitus is a common condition among pregnant women with metabolic implications for both the mother and offspring. Studies have suggested a potential role of vitamin D status in G...
Eligibility Criteria
Inclusion
- Pregnant women with 07-11 weeks of gestation
- 21 - 40 Years age range
- Pregnant women with high risk for GDM
- history of GDM in their previous pregnancy,
- one or more first-degree relative diagnosed with diabetes mellitus,
- overweight-BMI \>25 kg/m2 or obese-BMI \>30 kg/m2 at their first antenatal visit
- with a history of polycystic ovarian syndrome.
- Pregnant women with 07-11 weeks of gestation having normal response to 75g OGTT
- Low levels of Vitamin D3 (\<30ng/ml)
Exclusion
- Women already diagnosed with diabetes mellitus
- Any other systemic disease.
- High risk pregnant women diagnosed with diabetes on the basis of 75g OGTT
- High risk pregnant women with normal vitamin D3 levels (\>30ng/ml).
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06139133
Start Date
January 1 2024
End Date
December 1 2025
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan Railway Hospital
Rawalpindi, Punjab Province, Pakistan, 46000